Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Concurrent chemoimmunotherapy in metastatic clear cell sarcoma: a case report.

S Lauro1, F Bordin, L Trasatti

  • 1Division of Oncology, La Sapienza University, Rome, Italy.

Tumori
|April 25, 2000
PubMed
Summary

Concurrent chemoimmunotherapy for metastatic clear cell sarcoma, combining interferon alfa-2b and CyVEDIC chemotherapy, achieved 17 months of disease stabilization in a rare case.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The use of bone-modifying agents in early breast cancer: AIOM Guidelines update and perspectives.

Tumori·2025
Same author

KCTD1 is a new modulator of the KCASH family of Hedgehog suppressors.

Neoplasia (New York, N.Y.)·2023
Same author

Relationship between formaldehyde exposure, respiratory irritant effects and cancers: a review of reviews.

Public health·2023
Same author

Nutrition education in medical schools (NEMS) project: Joining ESPEN and university point of view.

Clinical nutrition (Edinburgh, Scotland)·2021
Same author

Mesenchymal cystic hamartoma presenting with pneumothorax: case report and review of the literature.

General thoracic and cardiovascular surgery·2020
Same author

Impact of Prior Platinum-Based Therapy on Patients Receiving Salvage Systemic Treatment for Advanced Urothelial Carcinoma.

Clinical genitourinary cancer·2016

Area of Science:

  • Oncology
  • Cancer Research

Background:

  • Clear cell sarcoma is a rare malignancy with a generally poor prognosis.
  • Treatment strategies for metastatic clear cell sarcoma remain controversial and underexplored.

Observation:

  • A 57-year-old male patient with metastatic clear cell sarcoma was treated with a novel therapeutic approach.
  • The treatment involved the simultaneous administration of subcutaneous interferon alfa-2b and six cycles of the CyVEDIC chemotherapy regimen.

Findings:

  • This concurrent chemoimmunotherapy approach resulted in a disease stabilization lasting 17 months.
  • To the authors' knowledge, this represents the first reported instance of concurrent chemoimmunotherapy for metastatic clear cell sarcoma.

Implications:

Related Experiment Videos

  • This case suggests that chemoimmunotherapy may be a viable treatment option for metastatic clear cell sarcoma.
  • Further research is warranted to evaluate the efficacy and safety of this combined therapeutic strategy in a larger patient cohort.